Evidence map›Paper›PMID 40874128›Full record

ArticleFrontiers in neurology2025

X-FASNet: cross-scale feature-aware with self-attention network for cognitive decline assessment in Alzheimer's disease.

Wenhui Chen, Shunwu Xu, Yiran Peng, Hong Zhang, Jian Zhang, Huaihao Zheng, Hao Yan, Zhaowen Chen

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenhui ChenKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Shunwu XuKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Yiran PengKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Hong ZhangKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Jian ZhangKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Huaihao ZhengKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Hao YanKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Zhaowen ChenKey Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early diagnosis of Alzheimer's disease is critical for effective therapeutic intervention. The progressive nature of cognitive decline requires precise computational methods to detect subtle neuroanatomical changes in prodromal stages. Current multi-scale neural networks have limited cross-scale feature integration capabilities, which constrain their effectiveness in identifying early neurodegenerative markers. This paper presents an Efficient Cross-Scale Feature-Aware Self-Attention Network (X-FASNet) designed to address these limitations through systematic hierarchical representation learning. The proposed architecture implements a dual-pathway multi-scale feature extraction approach to identify discriminative neuroanatomical patterns across various spatial resolutions, while integrating a novel cross-scale feature-aware self-attention module that enhances inter-scale information exchange and captures long-range dependencies. Quantitative evaluations on the DPC-SF dataset demonstrate that X-FASNet achieves superior performance with 93.7% accuracy and 0.973 F1-score, outperforming CONVADD by 10.8 percentage points in accuracy and 0.118 in F1-score, while also surpassing EfficientB2 on key performance metrics. Comprehensive experimentation across multiple neuroimaging datasets confirms that X-FASNet provides an effective computational framework for neurodegeneration assessment, characterized by enhanced detection of subtle anatomical variations and improved pathological pattern recognition.

Indexed as

Alzheimer's diseasecognitive decline assessmentcross-scale feature-aware self-attentionfeature fusionmulti-scale model

Identifiers

PMID40874128
PMCPMC12378860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.